Epstein-Barr virus and multiple sclerosis

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

(2022) Kjetil Bjornevik et al.   SCIENCE

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity

(2021) Melissa E. Munroe et al.   Frontiers in Immunology

Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model

(2019) Neelakshi R. Jog et al.   JOURNAL OF AUTOIMMUNITY

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

(2019) Katarina Tengvall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism

(2019) Barbara Serafini et al.   JOURNAL OF VIROLOGY

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

(2019) Amit Bar-Or et al.   TRENDS IN MOLECULAR MEDICINE

Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins

(2017) J. William Lindsey   JOURNAL OF NEUROIMMUNOLOGY

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

(2017) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE